查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1535302

DNA序列的到市場規模，佔有率，預測，趨勢分析:各產品，各技術，各用途，各終端用戶 - 2031年為止的世界預測

DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 235 Pages | 訂單完成後即時交付

價格

預計到 2031 年，全球 DNA 定序市場將達到 213 億美元，2024 年至 2031 年複合年增長率為 11.8%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業推動因素、阻礙因素、挑戰和機會進行了分析。

DNA定序市場的成長是由定序成本的下降、癌症和遺傳疾病發生率的增加、DNA定序在診斷和個人化醫療中的使用增加以及藥品研發投資的增加所推動的它受到多種因素的推動，包括積極的監管和報銷政策、高額醫療保健支出、測序技術的進步以及政府支持的旨在促進測序技術在臨床和研究應用中使用的舉措。然而，定序耗材的高成本、精準醫學中可操作變異的識別有限以及與基於 DNA 序列的診斷相關的倫理和法律問題等因素正在抑制這種增長。

此外，DNA 定序應用的擴大、政府對各種基因組學項目的支持、靶向治療的認識和採用的提高以及新興市場的經濟增長預計將為在該市場運營的公司提供增長機會。然而，監管的不確定性、小型實驗室的專業知識和測序能力有限、新興市場缺乏測序專家以及 NGS 基礎設施所需的高資本是限制市場成長的一些挑戰。

該市場的主要趨勢包括新興 DNA 定序公司專注於技術進步和成本降低，以及領先公司專注於開發便攜式和即時定序技術 You can。

本報告根據主要公司的產品組合和區域分佈提供了競爭格局，並對每家公司過去幾年（2021-2024 年）採用的主要成長策略進行了廣泛評估。全球DNA定序市場的主要公司有Illumina, Inc.（美國）、Thermo Fisher Scientific Inc.（美國）、F. Hoffmann-La Roche Ltd.（瑞士）、Revvity, Inc.（瑞士）、Revvity、 Inc.（美國）、QIAGEN NV（荷蘭）、Agilent Technologies, Inc.（美國）、Pacific Biosciences of California, Inc.（美國）、Danaher Corporation（美國）、Bio-Rad Laboratories, Inc.（美國）、牛津Nanopore Technologies Plc .（英國）和華大智造科技有限公司（中國）。

在本報告研究的產品中，耗材預計到 2024 年將主導 DNA 定序市場，佔總佔有率的 73.4%。這一巨大的市場佔有率歸因於最終用戶對消耗品的需求不斷增加、樣品製備材料的頻繁使用、可承受性的提高以及基因組作圖計劃的擴展。

在本報告調查的應用中，研究和其他應用領域預計到 2024 年將主導 DNA 定序市場，佔總佔有率的 67.2%。這一巨大的市場佔有率是由測序方法成本下降、製藥和生物技術公司對藥物發現的研發投資增加、NGS在各種臨床和研究環境中的日益使用、藥理學靶標的識別、資訊學的應用推動的。

在本報告調查的最終用戶中，製藥和生技公司預計到 2024 年將主導 DNA 定序市場，佔總佔有率的 44.7%。這一巨大的市場佔有率是由於製藥和生物技術公司研發支出的增加，以及慢性病的流行刺激了下一代定序產品的採用。

對全球 DNA 定序市場區域狀況的詳細分析提供了五個主要區域（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）的詳細定性和定量見解，並提供了主要國家的覆蓋範圍。到2024年，北美預計將主導市場，佔總佔有率的49.0%。另據預測，到2024年，美國將主導北美DNA定序市場。該地區巨大的市場佔有率歸因於政府對基因組研究的支持、基於測序的研究的擴大使用、下一代測序技術主要提供者的存在、製藥和生物製藥公司增加的研究投資以及較低的測序成本。這歸因於多種因素，包括需求下降、先進定序產品和解決方案的廣泛使用、癌症發病率上升以及該地區有利的報銷環境。

調查範圍:

DNA序列市場評估 - 各產品

  • 消耗品
    • 樣品製作套件及試劑
  • DNA萃取及放大
  • 品管
  • 其他的套件·試劑
    • 其他的消耗品
  • 設備
  • 軟體
  • 服務

注意：其他試劑盒和試劑包括稀釋緩衝液、DNA 標準品、DNA 淨化試劑、目標富集試劑和其他試劑。

DNA序列市場評估 - 各技術

  • 下一代序列
    • 合成的序列
    • 離子半導體序列
    • DNA奈米球序列
    • 單分子即時序列
    • 其他的NGS技術
  • 桑格定序及焦磷酸測序

註:其他的NGS技術奈米孔洞序列和AVITI序列

DNA序列市場評估 - 各用途

  • 研究及其他的用途
    • 藥物研發
    • 農業·動物研究
    • 其他的用途
  • 臨床應用
    • 生殖醫療
    • 腫瘤學
    • 感染疾病
    • 其他臨床應用

註：其他應用包括食品微生物學、食品和飲料行業的微生物組分析以及環境研究。

註：其他臨床應用包括檢測神經系統疾病、罕見疾病、代謝疾病和免疫疾病的遺傳異常。

DNA 定序市場評估 - 按最終用戶

  • 製藥和生技公司
  • 醫院和診斷實驗室
  • 學術機構與研究中心
  • 其他最終用戶

註：其他最終使用者包括法醫實驗室和安全機構、食品和飲料公司、農業公司等。

DNA序列市場評估 - 各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 其他南美國家
  • 中東·非洲

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場洞察

  • 概要
  • 市場成長的影響要素
    • 市場動態的影響分析
    • 要素分析
  • 價格分析
  • 產業趨勢
    • 新興 DNA 定序公司專注於改進技術和降低成本
    • 主要市場參與者對 PortTable 和即時定序技術的關注
  • 法規分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東
  • 波特的五力分析

第5章 DNA序列市場評估:各產品

  • 概要
  • 消耗品
    • 樣品製作套件及試劑
    • 其他的消耗品
  • 設備
  • 軟體
  • 服務

第6章 DNA序列的全球市場的評估:各技術

  • 概要
  • 下一代序列
    • 合成序列
    • 離子半導體序列
    • 單分子即時序列
    • DNA奈米球序列
    • 其他的NGS序列技術
  • 桑格定序和焦磷酸測序

第7章 DNA序列市場評估:各用途

  • 概要
  • 研究及其他的用途
    • 藥物研發
    • 農業·動物研究
    • 其他的用途
  • 臨床應用
    • 腫瘤學
    • 生殖醫療
    • 感染疾病
    • 其他臨床應用

第8章 DNA序列市場評估:各終端用戶

  • 概要
  • 製藥企業及生物科技企業
  • 醫院·診斷研究所
  • 學術·研究機關
  • 其他的終端用戶

第9章 DNA序列市場評估:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 其他南美國家
  • 中東·非洲

第10章 競爭分析

  • 概要
  • 主要成長策略
  • 競爭基準
  • 競爭儀表板
    • 產業領導者
    • 市場差異化要素
    • 領先企業
    • 新興企業
  • 市場佔有率分析(2023年)
    • Illumina, Inc.(U.S.)
    • Thermo Fisher Scientific Inc.(U.S.)
    • MGI Tech Co., Ltd.(China)
    • Agilent Technologies, Inc.(U.S.)
    • QIAGEN N.V.(Netherlands)

第11章 企業簡介(企業概要，財務概要，產品系列，策略性展開，SWOT分析)

  • Illumina, Inc.(U.S.)
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • MGI Tech Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies Plc.
  • Other Companies

第12章 附錄

Product Code: MRHC - 1041309

DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User-Global Forecast to 2031

The global DNA sequencing market is projected to reach $21.30 billion by 2031 at a CAGR of 11.8% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The DNA sequencing market's growth is driven by several factors, including the decreasing costs of sequencing, the rising incidence of cancer and genetic disorders, the rising use of DNA sequencing in diagnostics and personalized medicine, increased pharmaceutical R&D investments, favorable regulatory and reimbursement policies, high healthcare expenditures, advances in sequencing technology, and supportive government initiatives aimed at promoting the use of sequencing technology in clinical & research applications. However, factors such as the high cost of sequencing consumables, limited identification of actionable mutations for precision medicine, and ethical and legal concerns related to DNA sequencing-based diagnostics restrain this growth.

Moreover, the expanding applications of DNA sequencing, government support for extensive genomic projects, growing awareness and adoption of targeted therapies, and economic growth in emerging markets are anticipated to offer growth opportunities for companies operating in this market. However, regulatory uncertainties, limited expertise & sequencing capabilities among smaller laboratories, a shortage of sequencing professionals in developing regions, and the substantial capital required for NGS infrastructure are some of the challenges impeding the market's growth.

Key trends in this market include the focus of emerging DNA sequencing companies on technological advancements and cost reduction and the emphasis by major players on developing portable and real-time sequencing technologies.

The report offers a competitive landscape based on an extensive assessment of the key players' product portfolios and geographical presence and the key growth strategies adopted by them over the past few years (2021-2024). The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China).

Among the offerings studied in this report, in 2024, the consumables segment is projected to dominate the DNA sequencing market, capturing 73.4% of the total share. The significant market share is attributed to the growing demand for consumables from end users, frequent use of sample preparation materials, increasing affordability, and the expansion of genome mapping programs.

Among the applications studied in this report, in 2024, the research & other applications segment is projected to dominate the DNA sequencing market, capturing 67.2% of the total share. The significant market share is attributed to several factors: the declining cost of sequencing procedures, increased R&D investments by pharmaceutical and biotechnology companies in drug discovery, the expanding use of NGS in various clinical and research settings, and the application of informatics solutions to identify pharmacological targets, validate therapeutic hypotheses, and assess the potential safety of inhibitory compounds targeting molecular sites.

Among the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is projected to dominate the DNA sequencing market, capturing 44.7% of the total share. The significant market share is attributed to increased R&D expenditures by pharmaceutical & biotechnology companies and the growing prevalence of chronic diseases, which are fueling the adoption of next-generation sequencing products.

An in-depth analysis of the geographical scenario of the global DNA sequencing market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is projected to dominate the market, capturing 49.0% of the total share. Additionally, in 2024, the U.S. is expected to dominate the DNA sequencing market in North America. The region's significant market share can be attributed to several factors, including supportive government initiatives for genomic research, expanding applications of sequencing-based studies, the presence of leading next-generation sequencing technology providers, rising research investments by pharmaceutical and biopharmaceutical companies, decreasing sequencing costs, wide availability of advanced sequencing products and solutions, increasing cancer prevalence, and a favorable reimbursement environment in the region.

Scope of the Report:

DNA Sequencing Market Assessment-by Offering

  • Consumables
    • Sample Preparation Kits & Reagents
  • DNA Extraction & Amplification
  • Quality Control
  • Other Kits & Reagents
    • Other Consumables
  • Instruments
  • Software
  • Services

Note: Other Kits & Reagents Include dilution buffers, DNA standards, reagents for DNA cleanup, target enrichment, and other reagents

DNA Sequencing Market Assessment -by Technology

  • Next-Generation Sequencing
    • Sequencing by Synthesis
    • Ion Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Single-molecule Real-time Sequencing
    • Other NGS Technologies
  • Sanger Sequencing & Pyrosequencing

Note: Other NGS Technologies Nanopore Sequencing and AVITI Sequencing

DNA Sequencing Market Assessment -by Application

  • Research & Other Applications
    • Drug Discovery
    • Agriculture & Animal Research
    • Other Applications
  • Clinical Applications
    • Reproductive Health
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications

Note: Other Applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Note: Other Clinical Applications include the detection of genetic aberrations in neurological disorders, rare diseases, and metabolic and immune disorders.

DNA Sequencing Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic Institutes & Research Centers
  • Other End Users

Note: Other End Users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

DNA Sequencing Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Pricing Analysis
  • 4.4. Industry Trends
    • 4.4.1. Emerging DNA Sequencing Companies' Focus on Improving Technologies and Reducing Costs
      • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
      • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
      • 4.4.1.3. Element Biosciences (U.S.)
    • 4.4.2. Key Market Players' Emphasis on PorTable and Real-Time Sequencing Technologies
  • 4.5. Regulatory Analysis
    • 4.5.1. North America
      • 4.5.1.1. U.S.
      • 4.5.1.2. Canada
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
      • 4.5.3.1. China
      • 4.5.3.2. Japan
      • 4.5.3.3. India
    • 4.5.4. Latin America
    • 4.5.5. Middle East
  • 4.6. Porter's Five Forces Analysis

5. DNA Sequencing Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Sample Preparation Kits & Reagents
      • 5.2.1.1. Library Preparation
      • 5.2.1.2. DNA Extraction & Amplification
      • 5.2.1.3. Quality Control
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. Other Consumables
  • 5.3. Instruments
  • 5.4. Software
  • 5.5. Services

6. Global DNA Sequencing Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Next-generation Sequencing
    • 6.2.1. Sequencing by Synthesis
    • 6.2.2. Ion Semiconductor Sequencing
    • 6.2.3. Single-molecule Real-Time Sequencing
    • 6.2.4. DNA Nanoball Sequencing
    • 6.2.5. Other NGS Sequencing Technologies
  • 6.3. Sanger Sequencing & Pyrosequencing

7. DNA Sequencing Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Research & Other Applications
    • 7.2.1. Drug Discovery
    • 7.2.2. Agricultural & Animal Research
    • 7.2.3. Other Applications
  • 7.3. Clinical Applications
    • 7.3.1. Oncology
    • 7.3.2. Reproductive Health
    • 7.3.3. Infectious Diseases
    • 7.3.4. Other Clinical Applications

8. DNA Sequencing Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Hospitals & Diagnostic Laboratories
  • 8.4. Academic & Research Institutes
  • 8.5. Other End Users

9. DNA Sequencing Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (ROE)
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (ROAPAC)
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America (ROLATAM)
  • 9.6. Middle East & Africa (MEA)

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis (2023)
    • 10.5.1. Illumina, Inc. (U.S.)
    • 10.5.2. Thermo Fisher Scientific Inc. (U.S.)
    • 10.5.3. MGI Tech Co., Ltd. (China)
    • 10.5.4. Agilent Technologies, Inc. (U.S.)
    • 10.5.5. QIAGEN N.V. (Netherlands)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

  • 11.1. Illumina, Inc. (U.S.)
  • 11.2. Thermo Fisher Scientific Inc.
  • 11.3. QIAGEN N.V.
  • 11.4. Agilent Technologies, Inc.
  • 11.5. MGI Tech Co., Ltd.
  • 11.6. F. Hoffmann-La Roche Ltd
  • 11.7. Revvity, Inc.
  • 11.8. Pacific Biosciences of California Inc.
  • 11.9. Danaher Corporation
  • 11.10. Bio-Rad Laboratories, Inc.
  • 11.11. Oxford Nanopore Technologies Plc.
  • 11.12. Other Companies

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

LIST OF TABLES

  • Table 1 Number of New Cancer Cases, by Type, 2022 VS. 2040
  • Table 2 Common Genetic Disorders: Rates of Occurrence
  • Table 3 Major Genome Sequencing Projects, by Country
  • Table 4 Health Expenditure, by Country
  • Table 5 DNA Sequencing Kits & Reagents: Pricing
  • Table 6 DNA Sequencing Instruments: Product Description & Pricing
  • Table 7 G4 Specifications
  • Table 8 UG 100 Specifications
  • Table 9 AVITI Specifications
  • Table 10 Regulatory Authorities Governing In Vitro Diagnostics, by Country/REGION
  • Table 11 Global DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 12 Global DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 13 Global DNA Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 15 Global Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Library Preparation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global DNA Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Some of the Companies offering NGS Instruments for DNA Sequencing Are As Follows:
  • Table 22 Global DNA Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Key Players Offering DNA Sequencing Software
  • Table 24 Global DNA Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Key Players Offering Instrument-related Services
  • Table 26 Global DNA Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
  • Table 27 Global DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 28 Global NGS-Based Market, by Technology, 2022-2031 (USD Million)
  • Table 29 Global NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Sequencing by Synthesis Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Ion Semiconductor Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Single-Molecule Real-Time (SMRT) Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global DNA Nanoball Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Other NGS Sequencing Technologies Market, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global Sanger Sequencing & Pyrosequencing Market for DNA Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 37 Global DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 38 Global DNA Sequencing Market for Research & Other Applications, By Country/Region, 2022-2031 (USD Million)
  • Table 39 Global DNA Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global DNA Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global DNA Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 42 GLOBAL DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 43 GLOBAL DNA Sequencing Market for Clinical Applications, by COUNTRY/Region, 2022-2031 (USD Million)
  • Table 44 Global DNA Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global DNA Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 46 HIV Prevalence among Adults, by REGION (2020 VS. 2022) (In Million)
  • Table 47 Global DNA Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global DNA Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global DNA Sequencing Market, By End User, 2022-2031 (USD Million)
  • Table 50 Pharmaceutical Spending in Major Countries
  • Table 51 GLOBAL DNA Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 52 GLOBAL DNA Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 53 Global DNA Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global DNA Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 56 North America: DNA Sequencing Market, by Country, 2022-2031 (USD Million)
  • Table 57 North America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 58 North America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 59 North America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 60 North America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 61 North America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 62 North America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 63 North America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 64 North America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 65 North America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 66 U.S.: Key Macroindicators & Microindicators
  • Table 67 U.S.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 68 U.S.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 69 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.S.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 71 U.S.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 72 U.S.: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 73 U.S.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 74 U.S.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 75 U.S.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 76 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments and Genome Canada Contributions, Are As Follows:
  • Table 77 Canada: Key Macroindicators & Microindicators
  • Table 78 Canada: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 79 Canada: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 80 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 81 Canada: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 82 Canada: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 83 Canada: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 84 Canada: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 85 Canada: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 86 Canada: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 87 Europe: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 88 Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 89 Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 90 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 91 Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 92 Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 93 Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 94 Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 95 Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 96 Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 97 Germany: Key Macroindicators & Microindicators
  • Table 98 Germany: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 99 Germany: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 100 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 101 Germany: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 102 Germany: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 103 Germany: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 104 Germany: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 105 Germany: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 106 Germany: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 107 France: Key Macroindicators & Microindicators
  • Table 108 France: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 109 France: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 110 France: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 111 France: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 112 France: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 113 France: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 114 France: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 115 France: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 116 France: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 117 U.K.: Key Macroindicators & Microindicators
  • Table 118 U.K.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 119 U.K.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 120 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 121 U.K.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 122 U.K.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 123 U.K.: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 124 U.K.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 125 U.K.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 126 U.K.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 127 Italy: Key Macroindicators & Microindicators
  • Table 128 Italy: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 129 Italy: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 130 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 131 Italy: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 132 Italy: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 133 Italy: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 134 Italy: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 135 Italy: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 136 Italy: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 137 Spain: Key Macroindicators & Microindicators
  • Table 138 Spain: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 139 Spain: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 140 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 141 Spain: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 142 Spain: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 143 Spain: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 144 Spain: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 145 Spain: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 146 Spain: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 147 Number of Sequences In Each Phase and Other Related Sequencing Information:
  • Table 148 ROE: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
  • Table 149 Rest of Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 150 Rest of Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 151 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 152 Rest of Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 153 Rest of Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 154 Rest of Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 155 Rest of Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 156 Rest of Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 157 Rest of Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 158 Asia-Pacific: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 159 Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 160 Asia-Pacific: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 161 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 162 Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 163 Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 164 Asia-Pacific: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 165 Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 166 Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 167 Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 168 China: Key Macroindicators & Microindicators
  • Table 169 China: DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 170 China: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 171 China: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 172 China: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 173 China: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 174 China: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 175 China: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 176 China: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 177 China: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 178 Japan: Key Macroindicators & Microindicators
  • Table 179 Japan: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 180 Japan: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 181 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 182 Japan: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 183 Japan: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 184 Japan: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 185 Japan: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 186 Japan: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 187 Japan: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 188 INDIA: Key Macroindicators & Microindicators
  • Table 189 India: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 190 India: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 191 India: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 192 India: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 193 India: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 194 India: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 195 India: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 196 India: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 197 India: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 198 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
  • Table 199 Rest of Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 200 Rest of Asia-Pacific: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 201 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 202 Rest of Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 203 Rest of Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 204 Rest of Asia-Pacific: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 205 Rest of Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 206 Rest of Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 207 Rest of Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 208 Latin America: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 209 Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 210 Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 211 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 212 Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 213 Latin America: NGS-based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 214 Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 215 Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 216 Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 217 Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 218 Brazil: Key Macroindicators & Microindicators
  • Table 219 Brazil: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 220 Brazil: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 221 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 222 Brazil: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 223 Brazil: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 224 Brazil: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 225 Brazil: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 226 Brazil: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 227 Brazil: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 228 Mexico: Key Macroindicators & Microindicators
  • Table 229 Mexico: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 230 Mexico: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 231 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 232 Mexico: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 233 Mexico: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 234 Mexico: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 235 Mexico: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 236 Mexico: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 237 Mexico: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 238 Rest of Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 239 Rest of Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 240 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 241 Rest of Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 242 Rest of Latin America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 243 Rest of Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 244 Rest of Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 245 Rest of Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 246 Rest of Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 247 Middle East & Africa: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 248 Middle East & Africa: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 249 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 250 Middle East & Africa: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 251 Middle East & Africa: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 252 Middle East & Africa: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 253 Middle East & Africa: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 254 Middle East & Africa: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 255 Middle East & Africa: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 256 Recent Developments, by Company (2021-2024)
  • Table 257 Some of the Other Companies Operating in the DNA Sequencing Market

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global DNA Sequencing Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 8 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
  • Figure 9 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 10 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 11 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 12 Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024-2031)
  • Figure 13 Share Of Cancer Cases, By Region, 2022 vs. 2040 (%)
  • Figure 14 Genome Sequencing Costs, 2010-2021 (USD/GENOME)
  • Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, and China, 2010 VS. 2020 VS. 2021 (USD Million)
  • Figure 16 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
  • Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
  • Figure 19 EU Regulatory Pathway - IVDR 2017/746
  • Figure 20 China: Medical Device Classification and Premarket Requirements FOR IVD Products
  • Figure 21 Porter's Five Forces Analysis
  • Figure 22 Global DNA Sequencing Market, by offering, 2022 VS. 2031 (USD Million)
  • Figure 23 Steps of Sample Preparation in A Typical Next-Generation DNA Sequencing Workflow
  • Figure 24 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
  • Figure 25 Steps of DNB Sequencing Technology Include
  • Figure 26 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 27 U.S.: New Molecular Entity (NME) APPROVALS
  • Figure 28 Estimated Number of New Cancer Cases (Million)
  • Figure 29 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 30 Global Pharmaceutical R&D Spending, 2014-2028 (USD BILLION)
  • Figure 31 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 32 North America: DNA Sequencing Market Snapshot
  • Figure 33 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
  • Figure 34 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
  • Figure 35 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
  • Figure 36 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
  • Figure 37 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
  • Figure 38 Europe: DNA Sequencing Market Snapshot
  • Figure 39 Italy: Number of Biotechnology Firms, 2014-2022
  • Figure 40 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 41 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 42 Asia-Pacific: DNA Sequencing Market Snapshot
  • Figure 43 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
  • Figure 44 Japan: Number of New Molecular Entities Approved, 2014-2022
  • Figure 45 Latin America: DNA Sequencing Market Snapshot
  • Figure 46 Key Growth Strategies Adopted by Leading Players, 2021-2024
  • Figure 47 DNA Sequencing Market: Competitive Benchmarking by offering
  • Figure 48 DNA Sequencing Market: Competitive Benchmarking, by Region
  • Figure 49 Competitive Dashboard: DNA Sequencing Market
  • Figure 50 Global DNA Sequencing Market Share Analysis, by Key Players, 2023 (%)
  • Figure 51 Illumina, Inc.: Financial SNAPSHOT (2023)
  • Figure 52 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 53 QIAGEN N.V: Financial Snapshot (2023)
  • Figure 54 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 55 MGI Tech Co., Ltd.: Financial Snapshot (2023)
  • Figure 56 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 57 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 58 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 59 Danaher Corporation: Financial Snapshot (2023)
  • Figure 60 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
  • Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)